FRANKFURT (Reuters) - Munich Re is buying the 71% of Next Insurance that it doesn't already own, valuing the California-based company at $2.6 billion and strengthening its foothold in the United States, a division of the German company announced on Thursday. Ergo, the primary insurance business of reinsurer Munich Re, will become the sole owner of Next, which is focused on insuring U.S. small businesses. Until now, Next investors have included Allianz, Alphabet and American Express. It is the latest in a spate of deals affecting German insurance companies. "We will tap into a highly attractive market overseas, unlocking significant growth," Ergo's CEO Markus Riess said. Next was founded in 2016 and now has around 700 employees and 600,000 customers. Munich Re and Ergo have been investors since 2017. (Reporting by Tom Sims, Editing by Miranda Murray) View Comments
Germany's Munich Re to buy 71% of Next Insurance, valuing it at $2.6 billion
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...